Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
37,905,722
-
Share change
-
-458,760
-
Total reported value
-
$11,997,544,018
-
Put/Call ratio
-
97%
-
Price per share
-
$316.51
-
Number of holders
-
325
-
Value change
-
+$167,811,345
-
Number of buys
-
196
-
Number of sells
-
123
Institutional Holders of KARUNA THERAPEUTICS INC - COM (KRTX) as of Q4 2023
As of 31 Dec 2023,
KARUNA THERAPEUTICS INC - COM (KRTX) was held by
325 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,905,722 shares.
The largest 10 holders included
Capital International Investors, VANGUARD GROUP INC, FMR LLC, T. Rowe Price Investment Management, Inc., BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Sofinnova Investments, Inc., WELLINGTON MANAGEMENT GROUP LLP, Pentwater Capital Management LP, and GENERAL ATLANTIC, L.P..
This page lists
325
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.